FSH, inhibin B poor predictors of sperm count after cancer

FSH, inhibin B poor predictors of sperm count after cancer
Serum levels of follicle-stimulating hormone and inhibin B are not good predictors of sperm levels in male survivors of childhood cancer, according to a study published online Feb. 19 in the Journal of Clinical Oncology.

(HealthDay)—Serum levels of follicle-stimulating hormone (FSH) and inhibin B are not good predictors of sperm levels in male survivors of childhood cancer, according to a study published online Feb. 19 in the Journal of Clinical Oncology.

Daniel M. Green, M.D., from the St. Jude Children's Research Hospital in Memphis, Tenn., and colleagues investigated the association of of FSH and inhibin B with sperm concentration in 275 adult male survivors of childhood cancer who had received gonadotoxic treatment placing them at risk of azoospermia.

Based on receiver operating characteristic analysis, the researchers chose 11.5 mIU/mL FSH and 31 ng/L inhibin B as cutoffs. Using these cutoffs to identify azoospermic survivors, they found that serum FSH levels had a specificity of 74.1 percent and a of 65.1 percent, while serum inhibin B levels had a specificity of 45.0 percent and a positive predictive value of 52.1 percent.

"Neither serum inhibin B nor FSH is a suitable surrogate for determination of sperm concentration in a semen sample," Green and colleagues conclude.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

New hormone data can predict menopause within a year

Oct 27, 2008

For many women, including the growing number who choose later-in-life pregnancy, predicting their biological clock's relation to the timing of their menopause and infertility is critically important.

Men who do exercise produce better quality semen

Oct 31, 2012

A new study conducted by researchers at the University of Cordoba links moderate physical activity in males with better hormone levels and sperm characteristics that favour reproduction compared to sedentary ...

New weekly fertility injections work as well as daily

Jun 12, 2012

New long-lasting weekly injections of fertility hormones are as safe and effective as standard daily injections, according to Cochrane researchers. The researchers compared weekly and daily hormone injections in a Cochrane ...

Sperm may be harmed by exposure to BPA, study suggests

Aug 03, 2010

(PhysOrg.com) -- In one of the first human studies of its kind, researchers have found that urinary concentrations of the controversial chemical Bisphenol A, or BPA, may be related to decreased sperm quality and sperm concentration.

Recommended for you

Immune checkpoint inhibitors may work in brain cancers

5 hours ago

New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented today by Dr Anna Sophie Berghoff at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland.

New model of follow up for breast cancer patients

9 hours ago

Public health researchers from the University of Adelaide have evaluated international breast cancer guidelines, finding that there is potential to improve surveillance of breast cancer survivors from both a patient and health ...

Immunotherapy set to revolutionise cancer treatment

11 hours ago

Immunotherapy is set to revolutionise the treatment of cancer, according to ESMO President Professor Rolf A. Stahel. His comments come as the ESMO Symposium on Immuno-Oncology 2014 is about to open in Geneva, Switzerland ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.